Blood-brain barrier as a regulatory interface

Forum of Nutrition

Volumn 63, Issue , 2010, Pages 102-110

  Banks, William A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPETITE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DIGESTIVE FUNCTION; FEEDING BEHAVIOR; HUMAN; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

APPETITE; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DIGESTIVE SYSTEM PHYSIOLOGICAL PHENOMENA; FEEDING BEHAVIOR; HUMANS; OBESITY; SIGNAL TRANSDUCTION;

EID: 77649215791     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000264398     Document Type: Article

References (49)

1. Langhans W, Geary N: Overview of the physiological control of eating; in Langhans W, Geary N (eds): Frontiers in Eating and Weight Regulation. Forum Nutr. Basel, Karger, 2010, vol 63, pp 9-53.
2. Davson H: The blood-brain barrier; in: Physiology of the Cerebrospinal Fluid. London, Churchill, 1967, pp 82-103.
3. 131. J Clin Invest 1954:33:1252-1260.
4. Haugaard N, Vaughan M, Haugaard ES, Stadie WC: Studies of radioactive injected labeled insulin. J Biol Chem 1954:208:549-563.
5. Woods SC, Porte D Jr.: Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol 1977;233: E331-E334.
6. Kastin AJ, Coy DH, Schally AV, Miller LH: Peripheral administration of hypothalamic peptides results in CNS changes. Pharmacol Res Comm 1978;10:293-312.
7. Wilson JF, Anderson S, Snook G, Llewellyn KD: Quantification of the permeability of the blood-CSF barrier to α-MSH in the rat. Peptides 1984;5:681-685.
8. Banks WA, Kastin AJ: The interleukins-1α,-1β, and-2 do not disrupt the murine blood-brain barrier. Int J Immunopharmacol 1992;14:629-636.
9. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
10. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
11. Kastin A J, Pan W. Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides. Curr Pharmac Design 2008;14:1615-1619.
12. Hardebo JE, Owman C: Enzymatic barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain barrier; in Johansson BB, Owman C, Widner H (eds): Pathophysiology of the Blood-Brain Barrier. Amsterdam, Elsevier, 1990, pp 41-55.
13. Pardridge WM, Mietus LJ: Transport of steroid hormones through the rat blood-brain barrier: primary role of albumin-bound protein. J Clin Invest 1979;64:145-154.
14. Banks WA, Kastin AJ, Ehrensing CA: Diurnal uptake of circulating interleukin-1α by brain, spinal cord, testis and muscle. NIM 1998;5:36-41.
15. Pan W, Kastin AJ: Diurnal variation of leptin entry form blood to brain involving partial saturation of the transport system. Life Sci 2001;68:2705-2414.
16. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE: Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004;53:1253-1260.
17. Banks WA: Enhanced leptin transport across the blood-brain barrier by α1-adrenergic agents. Brain Res 2001;899:209-217.
18. Kastin AJ, Akerstrom V: Glucose and insulin increase the transport of leptin through the bloodbrain barrier in normal mice but not in streptozotocin-diabetic mice. Neuroendocrinology 2001;73:237-242.
19. Banks WA, DiPalma CR, Farrell CL: Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999;20:1341-1345.
20. Banks WA, Burney BO, Robinson SM: Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides 2008;29:2061-2065.
21. Urayama A, Banks WA: Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology 2008;149:3592-3597.
22. Florant GL, Richardson RD, Mahan S, Singer L, Woods SC: Seasonal changes in CSF insulin levels in marmots: insulin may not be a satiety signal for fasting in winter. Am J Physiol 1991;260: R712-R716.
23. Kastin AJ, Akerstrom V, Pan W: Activation of urocortin transport into brain by leptin. Peptides 2000;21:1811-1817.
24. Fabry Z, Fitzsimmons KM, Herlein JA, Moninger TO, Dobbs MB, Hart MN: Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 1993;47:23-34.
25. Mandi Y, Ocsovszki I, Szabo D, Nagy Z, Nelson J, Molnar J: Nitric oxide production and MDR expression by human brain endothelial cells. Anticancer Res 1998;18:3049-3052.
26. MCGuire TR, Trickler WJ, Hock L, Vrana A, Hoie EB, Miller DW: Release of prostaglandin E-2 in bovine brain endothelial cells after exposure to three unique forms of the antifungal drug amphotericin-B: role of COX-2 in amphotericin-B induced fever. Life Sci 2003;72:2581-2590.
27. Reyes TM, Fabry Z, Coe CL: Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res 1999;851:215-220.
28. Verma S, Nakaoke R, Dohgu S, Banks WA: Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain Behav Immun 2006;20:449-455.
29. Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschop M, Banks WA: Adiponectin does not cross the bloodbrain barrier, but modifies cytokine expression of brain endothelial cells. Diabetes 2006;55:141-147.
30. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B: Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003;285: E527-E533.
31. Kusminski CM, McTernan PG, Schraw T, Kos K, O'Hare J P, Ahima R, Kumar S, Scherer PE: Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 2007;50:634-642.
32. Caro JF, Kolaczynski J W, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MD, Considine RV: Decreased cerebrospinalfluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348:159-161.
33. Schwartz M W, Peskind E, Raskind M, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: relationship to plasma levels and adiposity in humans. Nat Med 1996;2:589-593.
34. Verhoeven GFM, Wilson JD: The syndromes of primary hormone resistance. N Engl J Med 1979;28:253-289.
35. van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano M P, Sybertz EJ, Strader CD, Davis J: Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997;99:385-390.
36. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997;94:8878-8883.
37. Münzberg H: Leptin-signaling pathways and leptin resistance; in Langhans W, Geary N (eds): Frontiers in Eating and Weight Regulation. Forum Nutr. Basel, Karger, 2010, vol 63, pp 123-132.
38. Banks WA: The blood-brain barrier as a cause of obesity. Curr Pharmac Design 2008;14:1606-1614.
39. Altmann J, Schoeller D, Altmann SA, Muruthi P, Sapolsky RM: Body size and fatness of free-living baboons reflect food availability and activity levels. Am J Primatol 1993;30:149-161.
40. Banks WA, Phillips-Conroy JE, Jolly CJ, Morley JE: Serum leptin levels in wild and captive populations of baboons (Papio): implications for the ancestral role of leptin. J Clin Endocrinol Metab 2001;86:4315-4320.
41. Eaton SB, Konner M: Paleolithic nutrition: a consideration of its nature and current implications. N Engl J Med 1985;312:283-289.
42. Morley JE: Anorexia of aging: physiologic and pathologic. Am J Clin Nutr 1997;66:760-773.
43. Elinav E, Niv-Spector L, Katz M, Price TO, Ali M, Yacobovitz M, Solomon G, Reicher S, Lynch JL, Halpern Z, Banks WA, Gertler A: Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology 2009;150:3083-3091.
44. Long JB, Rigamonti DD, Dosaka K, Kraimer JM, Martinez-Arizala A: Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system. J Pharmacol Exp Ther 1992;260:1425-1432.
45. Diano S, Farr SA, Benoit SE, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman M W, Tschop MH, Horvath TL: Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006;9:381-388.
46. Farr SA, Banks WA, Morley JE: Effects of leptin on memory processing. Peptides 2006;27:1420-1425.
47. Zhao WQ, Chen H, Quon MJ, Alkon DL: Insulin and the insulin receptor in expreimental models of learning and memory. Eur J Pharmacol 2004;490:71-81.
48. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH II, Craft S: Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired adults. J Alzheimer Dis 2008;13:323-331.
49. Kern W, Born J, Schreiber H, Fehm HL: Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 1999;48:557-563.